Graphic presentation of the costs of the NHIF for original and generic medicinal products for the period 2018-2022. as a total amount and distribution by INN in BGN. Legend: TM-trademark, GN- generic name, INN- international non-proprietary name.

 
 
  Part of: Goranova-Marinova V, Grekova-Kafalova D, Andreevska K, Georgieva V, Gvozdeva Y, Kassarova M, Grudeva-Popova Z, Gavazova E, Petkova V (2024) Analysis of the pharmacoeconomic effectiveness of the tyrosine kinase inhibitors therapy in patients with chronic myeloid leukemia in a Single Hematology Center in Plovdiv, Bulgaria. Pharmacia 71: 1-19. https://doi.org/10.3897/pharmacia.71.e126016